Association of preoperative and postoperative CA72‐4 with gastric cancer outcome

Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research

(2020) Ping Hu et al.   Gastric Cancer

Exhaled breath diagnostics of lung and gastric cancers in China using nanosensors

(2020) Alaa Gharra et al.   Cancer Communications

Clinical Evaluation of CA72-4 for Screening Gastric Cancer in A Healthy Population: A Multicenter Retrospective Study

(2019) Hu et al.   Cancers

A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes

(2019) Sharvesh Raj Seeruttun et al.   Cancer Communications

Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?

(2018) Jian-Xian Lin et al.   ANNALS OF SURGICAL ONCOLOGY

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4)

(2017) Jing Guo et al.   Oncotarget

Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study

(2016) Xuefeng Yu et al.   BMC CANCER

Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection

(2016) Xuechao Liu et al.   Oncotarget

Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients

(2015) Wei Wang et al.   ANNALS OF SURGICAL ONCOLOGY

Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer

(2015) Li-Kui Yin et al.   Asian Pacific Journal of Cancer Prevention

Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses

(2015) Se Hoon Park et al.   JOURNAL OF CLINICAL ONCOLOGY

A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer

(2014) Liang Liu et al.   INTERNATIONAL JOURNAL OF CANCER

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

(2014) Sung Hoon Noh et al.   LANCET ONCOLOGY

Comprehensive molecular characterization of gastric adenocarcinoma

(2014) Adam J. Bass et al.   NATURE

Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer

(2013) Chao-Zhu He et al.   BMC GASTROENTEROLOGY

Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association

(2013) Hideaki Shimada et al.   Gastric Cancer

The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy

(2011) Dae Hoon Kim et al.   JOURNAL OF SURGICAL ONCOLOGY

7th Edition of the AJCC Cancer Staging Manual: Stomach

(2010) Kay Washington   ANNALS OF SURGICAL ONCOLOGY

Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer

(2008) Edip Ucar et al.   ADVANCES IN THERAPY

D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer

(2008) Mitsuru Sasako et al.   NEW ENGLAND JOURNAL OF MEDICINE